Stay updated on Risdiplam in SMA Type 2/3: Clinical Trial
Sign up to get notified when there's something new on the Risdiplam in SMA Type 2/3: Clinical Trial page.

Latest updates to the Risdiplam in SMA Type 2/3: Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe study page now displays a 403 Forbidden error (with a minimal header and a Home link) instead of the full study record content for NCT02908685. This indicates blocked access rather than the usual display of the study details.SummaryDifference20%

- Check19 days agoChange DetectedA new page revision label, v3.7.0, was added and the previous revision label, v3.6.6, was removed, indicating the page has been updated to a newer version.SummaryDifference0.0%

- Check33 days agoChange DetectedThe page revision was updated from v3.6.5 to v3.6.6, indicating a minor editorial update to the study page.SummaryDifference0.0%

- Check40 days agoChange DetectedA line indicating NIH funding/contract information was added to the study's identifiers, clarifying the funding source and associated numbers.SummaryDifference0.0%

- Check54 days agoChange DetectedThe page's revision label was updated from v3.6.4 to v3.6.5, indicating a new revision of the study documentation. This update affects only the metadata and does not change the presented study data or results.SummaryDifference0.0%

- Check69 days agoChange DetectedThe page's revision designation was updated from v3.6.3 to v3.6.4, signaling a small template or rendering update.SummaryDifference0.0%

Stay in the know with updates to Risdiplam in SMA Type 2/3: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Risdiplam in SMA Type 2/3: Clinical Trial page.